New device aims to cut nerve damage in spine surgery
NCT ID NCT04639297
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study compares a new nerve monitoring device, NeuroVision®, to standard hospital monitoring during spine surgery. The goal is to see if NeuroVision® reduces the chance of nerve injury. About 148 adults having lateral spine surgery will be randomly assigned to one of the two monitoring methods.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- NeuroVision® IONM device
- What this could lead to
- If successful, this could show that NeuroVision® is better at preventing nerve damage during spine surgery than current monitoring methods.
- What could go wrong
- This is a relatively small, early-stage trial (148 participants). The device may not prove superior, and results may not apply to all spine surgeries.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CENTRAL STENOSIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Rush University Medical Center
RECRUITINGChicago, Illinois, 60612, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- AI as the first clinician: could symptom-checkers reshape spine care?
- 3D-Printed spinal cages could revolutionize back surgery
- Virtual reality goggles could replace pills for procedure pain
- Laser light may ease Pinched-Nerve pain without surgery
- Bone scan may help avoid unnecessary back surgery
- Can a simple quiz improve back pain care for troops?